International Master's Programme in Innovative Medicine 2020/2021

Photo for International Master's Programme in Innovative Medicine 2020/2021

Translational medicine strives towards bridging the gap from the research bench to the patient's bedside by the development of novel diagnostics and treatments. This is the core of the Erasmus+ International Master's Programme in Innovative Medicine (IMIM), a two-year programme aiming to provide knowledge, skills and competences for future careers in interdisciplinary and internationally competitive academic research or in the private sector.

Why this programme?

IMIM is a two-year international Master's programme focusing on translational medical research, modern molecular techniques, innovation and entrepreneurship. The programme is a European collaboration between the University of Groningen in the Netherlands, Heidelberg University in Germany, and Uppsala University in Sweden. A number of international Life Sciences companies are associated with the programme as well as other universities in Brazil, Chile, Colombia and Mexico.

Depending on a student's prior knowledge, the first year's studies are located in either Heidelberg, Groningen or Uppsala. In the second year, students must change university to either Groningen or Uppsala.

The IMIM programme trains you for research in both academia and industry, for example through a multidisciplinary group project - "Bench to Bedside and Back" (BBB), focused on translational medicine and the innovation process with business and entrepreneurship. The IMIM programme has received EIT Health's quality label.

You apply for the IMIM programme directly through the programme office in Groningen and not through Uppsala University or More information is available at the IMIM programme's international website.

Student profile

  • You want to gain skills and competences in translational medicine to work in international and interdisciplinary settings as a scientist or professional in academia or industry.
  • You have completed a Bachelor's degree in biochemistry, pharmaceutical sciences, biomedical sciences, genetics, molecular biology, biotechnology, medicine, dentistry, or similar with an excellent record.
  • You have gained extra-curricular experiences in research and/or work in private sector and can provide strong recommendation letters from your previous education, internships or employments.
  • You are curious and enjoy problem solving in creative and innovative ways.
  • You have excellent English skills and enjoy interacting with people from all over the world.
  • You are highly motivated to pursue a career in academic research or working with innovation and entrepreneurship in industry or in your own startup company.
  • You are prepared to work hard and take full responsibility for your studies.


The programme leads to a Master of Medical Science (120 credits) with Medical Science as the main field of study. With the requirements fulfilled it will also lead to a Master's degree from one of the other participating universities.


In the IMIM programme, you will study at two or each of the three European universities and have further opportunities to carry out research projects in industry, at affiliated universities in South America or at other universities.

Depending on you prior knowledge and admission, your first year at the universities of Uppsala, Heidelberg or Groningen will be spent in part with existing Master's programmes. The first semester at Uppsala University will provide you with in-depth knowledge of the molecular and cellular mechanisms that cause genetic diseases and cancer as well as current methods and techniques used in diagnostics and treatment.

You will perform a short research project, compile the results in a scientific article and present them at seminars. During the semester you will also follow a seminar series which includes bioinformatics, research and bioethics.

In order to stimulate innovative and translational thinking, the programme integrates in parallel with courses and research projects, a multidisciplinary group project - "Bench to Bedside and Back" (BBB) - focused on translational medicine, the innovation process with business leadership and entrepreneurship. During BBB1, which runs through the first semester, the success concepts of different research groups are analysed.

During semester two, you will perform a research project, in parallel with BBB2 where you design a research application. During the IMIM Spring School, skills in leadership, written and oral communication are trained, and a business fair is organised where contacts are made with a number of international companies

During semester three, you will carry out a research project, either at a university or in a company. In parallel, BBB3 runs where you prepare a business plan and further contacts with the industry are obtained through the IMIM Summer School IPIM - Industry Perspectives on Innovative Medicine, which deals with entrepreneurship, intellectual property and research funding.

The programme is concluded by the last semester with an individual degree project (30 credits) in the form of a research or development project carried out in a research group or a company, nationally or internationally.

To read more about the programme - see the IMIM programme's international website.

Courses within the programme

See outline for courses within the programme.

Learning experience

The teaching consists of lectures, seminars, assignments, laboratory exercises and project work, individually and in groups. Lecturers are researchers and experts in their field from academia and companies.

Seminars, labs and project work train you to critically review your own and others' results, compile and present data orally and in writing, and also to plan and conduct research projects.

The programme is given entirely in English.


The IMIM programme prepares you for a career in the global job market within academic research or the Life Science industry, as well as for starting up your own company. Graduates from IMIM have started their PhD studies at different international universities or gone directly into the job market.

You can read more about our alumni on the IMIM programme's international website.

Career support
During your whole time as a student UU Careers offers you support and guidance. You have the opportunity to partake in a variety of career activities and events, as well as receive individual career counselling. This service is free of charge for all students at Uppsala University. Read more about UU Careers.


You apply to the IMIM programme at, where you will find information about all the required application documents, the admission process, requirements and the selection criteria.

All admitted students must pay a participation fee to the central IMIM Coordination Office.

International Master's Programme in Innovative Medicine

120 credits

Autumn 2020 - 100 % - Campus

Location: Uppsala, Heidelberg, Groningen

Application Deadline: 2020-01-15


Language of Instruction: English

Requirements: The International Master's Programme in Innovative Medicine (IMIM) is a collaboration between Uppsala University, the University of Groningen, the Netherlands, and Heidelberg University, Germany, where admitted students study year 1 at either partner university and year 2 at either Groningen or Uppsala. This means that there are three different study plans where special eligibility for IMIM and the separate partner universities must be fulfilled.

Starting at Uppsala University:
A Bachelor's degree of at least 180 credits from education programmes in biochemistry, biology, biomedicine, biotechnology, genetics, molecular biology, medicine, pharmacy or a similar field of study that includes relevant knowledge in chemistry, biochemistry, cell and molecular biology and molecular-/genetics. Also required is previous experience of laboratory work.

Starting at the University of Groningen:
A Bachelor's degree in the fields of biology, pharmacy, life science and technology or (bio)medical sciences.

Starting at Heidelberg University:
A Bachelor's degree at least equivalent to a European undergraduate degree of 240 ECTS (usually at least four years) with above-average grades. The degree needs to be in medicine or the life sciences (e.g. biology, biochemistry, pharmaceutical sciences, biomedical sciences, genetics, molecular biology, biotechnology or closely related fields). Bioscientific and/or medical content must make up at least 60% of the curriculum studied. Proven record of academic and extra-curricular excellence as well as research experience. Strong motivation to pursue a career that incorporates translational, biomedical sciences and research.

Eligibility for IMIM and all three partner universities requires documented knowledge of English with results from an internationally accepted test.

The minimum test scores are:
IELTS (Academic) with an overall score of 6.5 - no less than 6.0 on each section
TOEFL iBT (internet-based test) with an overall score of 92 - no less than 21 on each section
TOEFL CBT (computer-based test) with an overall score of 237 - no less than 21 on each section
TOEFL PBT (paper-based test) with an overall score of 580 - no less than 55 on each section
or Cambridge Certificate of Proficiency in English (CPE)/Cambridge Certificate of Advanced English (CAE)

Selection: See for information about the selection procedure.

Contact and further resources

Is this programme right for you?


For enquiries about IMIM, please contact:

For information about the programme modules at Uppsala University, please contact:

UMCG - Graduate School of Medical Sciences

HPC FA33, Hanzeplein 1

9713 GZ Groningen, The Netherlands

Student portal

Student portal

The Student Portal provides logged-on students access to course and programme pages, study results, e-transcripts, information from the student unions, file area, webmail, and more. In order to log on, you must have applied for a student account. The course and programme pages in the Student Portal can be seen without being logged on here. The pages contain basic information plus those features that the department has chosen to make accessible.